These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23623327)

  • 21. Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgery.
    Penicka M; Linkova H; Lang O; Fojt R; Kocka V; Vanderheyden M; Bartunek J
    Circulation; 2009 Oct; 120(15):1474-81. PubMed ID: 19786637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mid-term results of coronary bypass graft surgery in patients with ischaemic left ventricular systolic dysfunction and no detected myocardial viability.
    Liu J; Liu Z; Chen A; Wang Z; Zhou M; Cai J; Zhao Q
    Interact Cardiovasc Thorac Surg; 2016 Jun; 22(6):738-43. PubMed ID: 26912575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell transplantation into ischemic myocardium using mesenchymal stem cells transfected by vascular endothelial growth factor.
    Hua P; Tao J; Liu JY; Yang SR
    Int J Clin Exp Pathol; 2014; 7(11):7782-8. PubMed ID: 25550816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair.
    Rufaihah AJ; Haider HK; Heng BC; Ye L; Tan RS; Toh WS; Tian XF; Sim EK; Cao T
    Regen Med; 2010 Mar; 5(2):231-44. PubMed ID: 20210583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood.
    Suuronen EJ; Veinot JP; Wong S; Kapila V; Price J; Griffith M; Mesana TG; Ruel M
    Circulation; 2006 Jul; 114(1 Suppl):I138-44. PubMed ID: 16820563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Morphological predictors of postoperative remodeling of the heart in patients with ischemic heart disease].
    Shipulin VM; Kazakov VA; Krivoshchekov EB; Sukhodolo IV; Vaizov VKh; Lezhnev AA; Stasev AN; Aliab'ev FV
    Kardiologiia; 2007; 47(8):57-9. PubMed ID: 18260914
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure.
    Schots R; De Keulenaer G; Schoors D; Caveliers V; Dujardin M; Verheye S; Van Camp G; Franken PR; Roland J; Van Riet I; Everaert H
    Exp Hematol; 2007 Dec; 35(12):1884-90. PubMed ID: 17923244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial.
    Colombo A; Castellani M; Piccaluga E; Pusineri E; Palatresi S; Longari V; Canzi C; Sacchi E; Rossi E; Rech R; Gerundini P; Viecca M; Deliliers GL; Rebulla P; Soligo D; Giordano R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):239-48. PubMed ID: 21372740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting.
    Yerebakan C; Kaminski A; Westphal B; Liebold A; Steinhoff G
    Minim Invasive Ther Allied Technol; 2008; 17(2):143-8. PubMed ID: 18465448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection.
    Pompilio G; Cannata A; Peccatori F; Bertolini F; Nascimbene A; Capogrossi MC; Biglioli P
    Ann Thorac Surg; 2004 Nov; 78(5):1808-12. PubMed ID: 15511478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discussion to: Stem cell-derived exosome patch with coronary artery bypass graft restores cardiac function in chronically ischemic porcine myocardium.
    J Thorac Cardiovasc Surg; 2023 Dec; 166(6):e531-e532. PubMed ID: 37804255
    [No Abstract]   [Full Text] [Related]  

  • 33. Outcome after redo coronary artery bypass grafting in patients with ischaemic cardiomyopathy and viable myocardium.
    Rizzello V; Poldermans D; Schinkel AF; Biagini E; Boersma E; Elhendy A; Sozzi FB; Palazzuoli A; Maat A; Crea F; Bax JJ
    Heart; 2007 Feb; 93(2):221-5. PubMed ID: 16905627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraoperative isolation and processing of BM-derived stem cells.
    Ghodsizad A; Klein HM; Borowski A; Stoldt V; Feifel N; Voelkel T; Piechaczek Ch; Burchardt E; Stockschläder M; Gams E
    Cytotherapy; 2004; 6(5):523-6. PubMed ID: 15512919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure.
    Bonaros N; Rauf R; Werner E; Schlechta B; Rohde E; Kocher A; Bonatti J; Laufer G
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):249-55. PubMed ID: 17925321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of coronary artery bypass graft surgery combined with stem cell transplantation in the treatment of ischemic heart diseases.
    Qin SL; He CY; Xu JS; Lai XY; Liu SS; He WP
    Coron Artery Dis; 2015 Mar; 26(2):170-5. PubMed ID: 25415856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress injury during cardiac surgery: how important is it?
    Chambers DJ
    Cardiovasc Res; 2007 Mar; 73(4):626-8. PubMed ID: 17274969
    [No Abstract]   [Full Text] [Related]  

  • 38. [Surgical Treatment of Left Main Trunk Coronary Artery Aneurysm with Asymptomatic Myocardial Ischemia;Report of a Case].
    Okugi S; Saito H; Umeda E; Takiguchi Y
    Kyobu Geka; 2017 May; 70(5):381-384. PubMed ID: 28496086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Roentgenomorphological features of coronary artery lesions and coronary shunts in patients with relapse of myocardium ischemia after coronary bypass surgery].
    Iurchenko DL; Denisiuk DO; Sharafutdinov VE; Volkov AM; Iakovlev NN; Paĭvin AA; Vlasenko SV
    Vestn Khir Im I I Grek; 2013; 172(2):15-9. PubMed ID: 24000672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CD133+ cell as advanced medicinal product for myocardial and limb ischemia.
    Bongiovanni D; Bassetti B; Gambini E; Gaipa G; Frati G; Achilli F; Scacciatella P; Carbucicchio C; Pompilio G
    Stem Cells Dev; 2014 Oct; 23(20):2403-21. PubMed ID: 25014242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.